(Q45326932)

13 December 2017

title

Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution (English)

1 reference

13 December 2017

1 reference

Julian W E Jarman

1

1 reference

13 December 2017

Karen Lascelles

2

1 reference

13 December 2017

Tom Wong

3

1 reference

13 December 2017

Vias Markides

4

1 reference

13 December 2017

Jonathan R Clague

5

1 reference

13 December 2017

Janice Till

6

1 reference

13 December 2017

publication date

8 March 2012

1 reference

13 December 2017

published in

European Heart Journal

1 reference

13 December 2017

volume

33

1 reference

13 December 2017

issue

11

1 reference

13 December 2017

page(s)

1351-1359

1 reference

Performance and survival of transvenous defibrillation leads: need for a European data registry

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

An entirely subcutaneous implantable cardioverter-defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

A European perspective on lead extraction: part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

Pacemaker lead infection in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

ICD therapy in children and young adults: low incidence of inappropriate shock delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

A prospective randomized-controlled trial of ventricular fibrillation detection time in a DDDR ventricular defibrillator. Ventak AV II DR Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS017

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHS017

1 reference

13 December 2017

1 reference